Department of Structural & Computational Biology, Max F. Perutz Laboratories, University of Vienna, Vienna Biocenter, Vienna Biocenter Campus 5, A-1030, Vienna, Austria.
Max F. Perutz Laboratories, Medical University of Vienna, Vienna Biocenter, Dr. Bohr-Gasse 9/3, A-1030, Vienna, Austria.
Sci Rep. 2017 Jun 6;7(1):2848. doi: 10.1038/s41598-017-03220-y.
Porphyromonas gingivalis and Porphyromonas endodontalis are important bacteria related to periodontitis, the most common chronic inflammatory disease in humans worldwide. Its comorbidity with systemic diseases, such as type 2 diabetes, oral cancers and cardiovascular diseases, continues to generate considerable interest. Surprisingly, these two microorganisms do not ferment carbohydrates; rather they use proteinaceous substrates as carbon and energy sources. However, the underlying biochemical mechanisms of their energy metabolism remain unknown. Here, we show that dipeptidyl peptidase 11 (DPP11), a central metabolic enzyme in these bacteria, undergoes a conformational change upon peptide binding to distinguish substrates from end products. It binds substrates through an entropy-driven process and end products in an enthalpy-driven fashion. We show that increase in protein conformational entropy is the main-driving force for substrate binding via the unfolding of specific regions of the enzyme ("entropy reservoirs"). The relationship between our structural and thermodynamics data yields a distinct model for protein-protein interactions where protein conformational entropy modulates the binding free-energy. Further, our findings provide a framework for the structure-based design of specific DPP11 inhibitors.
牙龈卟啉单胞菌和牙髓卟啉单胞菌是与牙周炎相关的重要细菌,牙周炎是全球范围内最常见的慢性炎症性疾病。其与 2 型糖尿病、口腔癌和心血管疾病等系统性疾病的合并症仍然引起了相当大的兴趣。令人惊讶的是,这两种微生物不能发酵碳水化合物;相反,它们将蛋白质底物用作碳和能源来源。然而,其能量代谢的潜在生化机制仍不清楚。在这里,我们表明二肽基肽酶 11(DPP11)是这些细菌中的一种中心代谢酶,在肽结合时会发生构象变化,从而将底物与终产物区分开来。它通过熵驱动的过程结合底物,通过焓驱动的方式结合终产物。我们表明,增加蛋白质构象熵是通过酶的特定区域展开(“熵库”)来结合底物的主要驱动力。我们的结构和热力学数据之间的关系为蛋白质-蛋白质相互作用提供了一个独特的模型,其中蛋白质构象熵调节结合自由能。此外,我们的发现为基于结构的特异性 DPP11 抑制剂设计提供了一个框架。